CANNABISEUTICAL(s), Improving Patient Quality of Life through "Strain Specific Cannabis Research and Development" ℠™ A brand of botanical AND cannabinoid medicines, patient formulated space. Hello welcome I am Michael a producer and I am a patient cannabis research FELLOW for 15 years; I desire to offer a better quality of life for the suffering. The end of marijuana prohibition is upon us. This movement is being fueled on two fronts: 1) the medical community who realized the healing potential and relative safety of this medication and 2) the anti-prohibitionists who realized that prohibition will never work (as with alcohol); see the business and societal gains inherent in outright legalization. Much of the impetus for legalization is the failing governmental financial structures and the realization that taxing the already prevalent use of marijuana will result in significant tax revenue paid into the system: Cannabiseutical(s) Inc. a brand. Established in 2001, registered in the state of Oregon in 2013. The initial entry into the market will be through medical cannabis dispensaries products. Cannabiseuticals product line are ailment specific. , which will utilize an integrative medical model, not merely dispensaries for product, a "triage*. The model starting with the first location, will house not only a MMJ dispensary staffed by Strain per Ailment© specialists; Cannabiseutical(s) Inc. includes an entire herbal dispensary (staffed by qualified herbalist), an extraction lab integrating terpenes and other botanical. Utilizing IP growth techniques and extraction methods H2o. Cannabiseuticals will only be licensing our brand name for the near term: [email protected]. 2000, I tested positive for liver enzymes, a liver biopsy was done and I was found to have Hepatitis C, genome type 2B. I live with it and I have managed to reduce the viral load and side effects by utilizing a cannabis protocol.